Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	1471
Country	Italy

Received	2012-12-13 14:40
Peer-Review Started	2012-12-13 15:57
To Make the First Decision	2013-01-09 15:57
Return for Revision	2013-01-10 13:37
Revised
Second Decision	2013-05-09 12:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-05-10 09:51
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-06-04 17:04
Publish the Manuscript Online	2013-11-17 20:09

ISSN	2218-6220 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Topic Highlights
Article Title	Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints
Manuscript Source	Invited Manuscript
All Author List	Paolo Sammartino, Tommaso Cornali, Marialuisa Framarino dei Malatesta and Pompiliu Piso
Funding Agency and Grant Number
Corresponding Author	Paolo Sammartino, MD, Department of Surgery Pietro Valdoni, Rome, Policlinico Umberto I, Via del Policlinico, 00161 Rome, Italy. paolo.sammartino@uniroma1.it
Key Words	Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Secondary cytoreduction; Surgery for Platinum sensitive ovarian cancer; Surgery for Platinum resistant ovarian cancer
Core Tip	The chief surgical problem to face after primary treatment is recurrent ovarian cancer. The role of surgery in recurrent ovarian cancer remains poorly defined. Current data, albeit from non-randomized studies, nevertheless clearly support surgical cytoreduction in selected patients, a rarely curative expedient that invariably yields a marked survival advantage over chemotherapy alone. Despite these findings, some consider it too early to adopt secondary cytoreduction as the standard care for patients with recurrent ovarian cancer and a randomized study is needed.
Publish Date	2013-11-17 20:09
Citation	Sammartino P, Cornali T, dei Malatesta MF, Piso P. Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints. World J Obstet Gynecol 2013; 2(4): 101-107
URL	http://www.wjgnet.com/2218-6220/full/v2/i4/101.htm
DOI	http://dx.doi.org/10.5317/wjog.v2.i4.101

Full Article (PDF)	WJOG-2-101.pdf
Manuscript File	1471-Review.doc
Answering Reviewers	1471-Answering reviewers.pdf
Copyright License Agreement	1471-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	1471-Language certificate.pdf
Peer-review Report	1471-Peer review.pdf
Scientific Editor Work List	1471-Scientific editor work list.doc